FIM
NVO

Freedom Investment Management’s Novo Nordisk NVO Stock Holding History

Freedom Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,557
Closed -$1.56M – 497
2025
Q2 		$1.56M Buy
22,557
+1,753
+8% +$119K 0.12% 144
2025
Q1 		$1.44M Buy
20,804
+3,406
+20% +$281K 0.12% 149
2024
Q4 		$1.5M Sell
17,398
-879
-5% -$95.1K 0.12% 144
2024
Q3 		$2.18M Sell
18,277
-1,058
-5% -$141K 0.17% 95
2024
Q2 		$2.76M Sell
19,335
-4,179
-18% -$554K 0.23% 79
2024
Q1 		$3.02M Sell
23,514
-4,690
-17% -$558K 0.24% 76
2023
Q4 		$2.92M Buy
28,204
+4,753
+20% +$470K 0.24% 78
2023
Q3 		$2.13M Buy
+23,451
New +$2.07M 0.26% 86
2023
Q2 		– Sell
-15,626
Closed -$1.24M – 744
2023
Q1 		$1.24M Buy
+15,626
New +$1.11M 0.14% 191
2022
Q2 		– Sell
-4,890
Closed -$272K – 808
2022
Q1 		$272K Buy
+4,890
New +$251K 0.02% 644
2021
Q1 		– Sell
-10,206
Closed -$356K – 885
2020
Q4 		$356K Sell
10,206
-894
-8% -$30.9K 0.04% 431
2020
Q3 		$385K Sell
11,100
-1,796
-14% -$59.9K 0.04% 352
2020
Q2 		$422K Buy
12,896
+6,176
+92% +$197K 0.05% 322
2020
Q1 		$212K Sell
6,720
-2,542
-27% -$75.7K 0.02% 615
2019
Q4 		$268K Sell
9,262
-1,118
-11% -$31K 0.02% 524
2019
Q3 		$268K Sell
10,380
-70
-0.7% -$1.77K 0.02% 552
2019
Q2 		$267K Sell
10,450
-3,860
-27% -$95.4K 0.02% 564
2019
Q1 		$374K Buy
14,310
+360
+3% +$8.85K 0.03% 456
2018
Q4 		$321K Sell
13,950
-400
-3% -$8.89K 0.03% 554
2018
Q3 		$350K Sell
14,350
-282
-2% -$6.88K 0.02% 662
2018
Q2 		$337K Sell
14,632
-670
-4% -$15.9K 0.02% 715
2018
Q1 		$377K Sell
15,302
-1,568
-9% -$41.2K 0.02% 788
2017
Q4 		$453K Sell
16,870
-2,124
-11% -$54K 0.02% 675
2017
Q3 		$457K Buy
18,994
+806
+4% +$18.2K 0.03% 638
2017
Q2 		$390K Sell
18,188
-17,080
-48% -$345K 0.02% 673
2017
Q1 		$604K Buy
35,268
+12,698
+56% +$221K 0.04% 473
2016
Q4 		$405K Buy
22,570
+3,644
+19% +$66.1K 0.03% 568
2016
Q3 		$394K Buy
18,926
+2,070
+12% +$51.3K 0.03% 523
2016
Q2 		$453K Sell
16,856
-2,760
-14% -$75.7K 0.03% 445
2016
Q1 		$532K Sell
19,616
-436
-2% -$11.7K 0.04% 382
2015
Q4 		$582K Sell
20,052
-10,682
-35% -$296K 0.04% 353
2015
Q3 		$155K Buy
30,734
+3,238
+12% +$91.7K 0.02% 632
2015
Q2 		$753K Buy
27,496
+10,188
+59% +$286K 0.08% 222
2015
Q1 		$462K Buy
17,308
+3,940
+29% +$90.7K 0.05% 333
2014
Q4 		$283K Sell
13,368
-1,560
-10% -$34.8K 0.04% 435
2014
Q3 		$355K Sell
14,928
-11,346
-43% -$261K 0.06% 297
2014
Q2 		$607K Buy
26,274
+13,528
+106% +$299K 0.1% 184
2014
Q1 		$291K Buy
+12,746
New +$272K 0.06% 299

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Freedom Investment Management's NVO Position: Q3 2025 in Review

Freedom Investment Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 22,557 shares — an estimated $1.56M sold.

Freedom Investment Management first reported a position in NVO in Q1 2014 and held it in 38 quarters. The position peaked at $3.02M in Q1 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Freedom Investment Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 22,557 Novo Nordisk shares in Q3 2025, an estimated $1.56M.
  • Freedom Investment Management first reported a position in Novo Nordisk in Q1 2014 and held it in 38 quarters.
  • Freedom Investment Management's Novo Nordisk position peaked at $3.02M in Q1 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.